Arch Gynecol Obstet (2017) 296:519–526 DOI 10.1007/s00404-017-4465-y GENERAL GYNECOLOGY Emergence of Candida glabrata in vulvovaginal candidiasis should be attributed to selective pressure or virulence ability? 1 2 3 Sandra Sayuri Nakamura‑Vasconcelos · Adriana Fiorini · Pamela Delvas Zanni · 1 1 4 Patrícia de Souza Bonfim‑Mendonça · Janine Ribeiro Godoy · Adriana Araújo Almeida‑Apolonio · 3 1 Marcia Edilaine Lopes Consolaro · Terezinha Inez Estivalet Svidzinski Received: 12 June 2017 / Accepted: 12 July 2017 / Published online: 20 July 2017 © Springer-Verlag GmbH Germany 2017 Abstract Conclusion These results allow hypothesizing that C. Purpose Vulvovaginal candidiasis (VVC) is one of glabrata is an emergent agent in VVC probably because the the most frequent female genital disorders and Candida treatment with fluconazole selects this species. But once glabrata is the second most common agent. Current study adhered, yeasts remain on biotic or abiotic surfaces causing was aimed to study the susceptibility to antifungal agents of colonization or VVC symptomatology. C. glabrata isolated from vaginal samples and some viru- lence attributes in order to better understand why this spe- Keywords Candida glabrata · Fluconazole · Drug cies is emerging as the main VVC agents. resistance · Adherence · Biofilm Methods A total of 60 C. glabrata vaginal isolates were included in this study. Firstly they were screened by sus- ceptibility tests to antifungal agents. The
Archives of Gynecology and Obstetrics – Springer Journals
Published: Jul 20, 2017
It’s your single place to instantly
discover and read the research
that matters to you.
Enjoy affordable access to
over 12 million articles from more than
10,000 peer-reviewed journals.
All for just $49/month
Read as many articles as you need. Full articles with original layout, charts and figures. Read online, from anywhere.
Keep up with your field with Personalized Recommendations and Follow Journals to get automatic updates.
It’s easy to organize your research with our built-in tools.
Read from thousands of the leading scholarly journals from SpringerNature, Elsevier, Wiley-Blackwell, Oxford University Press and more.
All the latest content is available, no embargo periods.
“Hi guys, I cannot tell you how much I love this resource. Incredible. I really believe you've hit the nail on the head with this site in regards to solving the research-purchase issue.”Daniel C.
“Whoa! It’s like Spotify but for academic articles.”@Phil_Robichaud
“I must say, @deepdyve is a fabulous solution to the independent researcher's problem of #access to #information.”@deepthiw
“My last article couldn't be possible without the platform @deepdyve that makes journal papers cheaper.”@JoseServera